Endostar®:Recombinant Human Endostatin Injection
Endostar®:Recombinant Human Endostatin Injection
  • Seen : 136 View

0
Endostar®:Recombinant Human Endostatin Injection

It is the first listed class I anti-tumor drug in the world, with patents from China and the United States. In addition, it has won the second prize of National Technological Invention Award and China Patent Gold Award, and has been listed in the National Medical Insurance Catalog since 2017.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form
No comments have been posted yet
loading
Your comment has been sent
Endostar®:Recombinant Human Endostatin Injection

It is the first listed class I anti-tumor drug in the world, with patents from China and the United States. In addition, it has won the second prize of National Technological Invention Award and China Patent Gold Award, and has been listed in the National Medical Insurance Catalog since 2017.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form